The Pharmacokinetics of CPZEN-45, a Novel Anti-Tuberculosis Drug, in Guinea Pigs
Lucila Garcia-Contreras, Shumaila Nida Muhammad Hanif, Mariam Ibrahim, Phillip Durham, Anthony J Hickey, Carsten Ehrhardt, Wenlei Jiang · 2023
Read The Pharmacokinetics of CPZEN-45, a Novel Anti-Tuberculosis Drug, in Guinea Pigs by Lucila Garcia-Contreras, Shumaila Nida Muhammad Hanif, Mariam Ibrahim, Phillip Durham, Anthony J Hickey, Carsten Ehrhardt, Wenlei Jiang (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10748184.txt.
Description
Lucila Garcia-Contreras and co-authors map how a new tuberculosis drug moves through the body in guinea pigs, in a study from 2023. The drug works against both standard and drug-resistant forms of the disease. Inhaled powder could deliver it straight to the lungs, but dose timing had to be worked out first.
They compared vein, under-skin, and direct lung dosing, then tested inhaled powder given back-to-back or spaced out. Lung dosing absorbed faster, lasted longer, and reached the blood more fully than under-skin dosing. Spaced doses held useful levels in blood and lung far longer than packed doses, so spaced dosing is advised for later cure tests.
Catalog record
| CREATOR | Lucila Garcia-Contreras, Shumaila Nida Muhammad Hanif, Mariam Ibrahim, Phillip Durham, Anthony J Hickey, Carsten Ehrhardt, Wenlei Jiang |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |